HANAROSTENT LowAxTM Colon/Rectum(NNN): payments to doctors
Payments that named HANAROSTENT LowAxTM Colon/Rectum(NNN) as the associated device or medical supply, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $210K
- Providers
- 134
- Transactions
- 210
- Average per transaction
- $998
The per-transaction average — $998 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 134 providers the average total is $1,564, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Olympus Corporation Of The Americas | $191,394 | 91.3% |
| Olympus America Inc. | $18,222 | 8.7% |